Pharmacist · Epidemiologist · Public Health Researcher

Yusuff Adebayo
Adebisi

Pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research across antimicrobial resistance, tobacco harm reduction and smoking cessation, and pandemic preparedness, with a focus on health systems, policy, and population-level risk.

Yusuff Adebayo Adebisi — Epidemiologist and Public Health Researcher

Research Contributions

250+
Publications
4,700+
Citations
38
h-index
90
i10-index

About

Advancing health equity through evidence

Yusuff Adebayo Adebisi is a pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research. He serves as Director of Research at Global Health Focus, leading applied research and capacity-strengthening initiatives across the Global South.

His work focuses on antimicrobial resistance, tobacco harm reduction, and pandemic preparedness, with a strong emphasis on real-world evidence, administrative data, and translating science into policy impact. He actively promotes bidirectional knowledge exchange between the Global North and South.

Yusuff has authored or co-authored 250+ peer-reviewed publications across infectious and non-communicable disease epidemiology and population health. His research leadership and social impact have been recognised internationally, including with the Diana Award, honouring young leaders driving positive social change.

He holds an MSc from the University of Oxford, a Bachelor of Pharmacy from the University of Ibadan, and is currently a PhD Researcher at the University of Glasgow.

Yusuff Adebisi presenting public health research at a conference

Research Domains

Antimicrobial ResistanceTobacco Harm ReductionSmoking CessationInfectious Disease EpidemiologyPandemic PreparednessDisability & Health

Methodological Focus

Linked Administrative DataPharmacoepidemiologySocial EpidemiologyPopulation-based StudiesSurvival AnalysisLarge-scale Cohort StudiesRandomised Controlled Trial

Cross-cutting Themes

Health EquityGlobal Health PolicyDecolonising ResearchMarginalised PopulationsScientific Publishing Equity

Experience

Research & Professional Appointments

2025 – Present
Università di Catania, Sicily, Italy

Visiting Research Scientist

Conducting interdisciplinary research on tobacco use, nicotine dependence, and smoking cessation. Contributing to projects examining harm reduction, cessation pathways, and population health impacts of nicotine products.

2019 – Present
Global Health Focus, Abuja, Nigeria

Research Lead (Director)

Leading multi-country research and advocacy initiatives spanning 26+ countries, coordinating international teams to advance health equity and support community-led evidence generation.

2023 – 2026
SCADR, University of Edinburgh, UK

Associate Researcher

Quantifying severe COVID-19 risk among individuals with disabilities in relation to household living conditions, using large-scale linked administrative data including Census, Public Health Scotland, and Ordnance Survey datasets.

2022 – 2023
Big Data Institute, University of Oxford, UK

Researcher, Clinical Trials & Epidemiological Studies Unit

Led a project quantifying risks of severe infectious respiratory diseases associated with tobacco smoking using the China Kadoorie Biobank (512,700 participants).

2021 – 2022
Blavatnik School of Government, University of Oxford, UK

Research Assistant — Oxford COVID-19 Government Response Tracker

Contributed to evaluating global policy responses and developing the COVID-19 Stringency Index through data collection, analysis, and dissemination.

Yusuff Adebisi speaking at the GHF Global Health Youth Conference 2025

Education

Academic Background

Doctor of Philosophy (Epidemiology)

University of Glasgow, Scotland, UK

Dissertation: Living with disabilities, household conditions and COVID-19 — a population-based study using linked administrative data (5.3 million participants).

United Kingdom Research and Innovation Economic and Social Research Council Funded
2023 – 2027

MSc Global Health Science & Epidemiology

University of Oxford, United Kingdom

Dissertation: Tobacco smoking and risk of severe infectious respiratory diseases — findings from the China Kadoorie Biobank (512,700 participants).

Commonwealth Scholarship
2022 – 2023

Bachelor of Pharmacy — Distinction

University of Ibadan, Nigeria

Dissertation: Understanding Smoking Cessation — From Pharmacy Education to Practice in Nigeria.

2015 – 2020
Yusuff Adebisi in formal academic setting as an epidemiologist

Publications

250+ Peer-Reviewed Publications

A selection of work across high-impact journals, original research, and academic commentary.

Yusuff Adebisi presenting on Antimicrobial Resistance and Marginalised Populations

Latest First-Author Publications

Health Science Reports

Prescribed Medication Burden by Tobacco Smoking and E-Cigarette Use Status

Adebisi YA, Uzairue LI, Farayola RO, Iyagbaye E, Ong CJN, Benson AE, Muzondo NV, Temitope AD · 2026

Published: 9 March 2026

Health Sci Rep. 2026;9(3):e72072. doi: 10.1002/hsr2.72072. PMID: 41816648; PMCID: PMC12971602.

Read →

Current Addiction Reports

Socioeconomic Disparities in E-Cigarette Use: Patterns, Mechanisms, and Equity Implications

Adebisi YA · 2026

Published: 17 February 2026

Curr Addict Rep 13, 11 (2026)

Read →

High-Impact Publications

IF 168 Nature

Vaccinate people in Africa's prisons against COVID-19

Adebisi YA, Okoya F, Lucero-Prisno DE · 2021

Read →

IF 98 The Lancet

Antimicrobial resistance and people living with disabilities

Adebisi YA · 2024

Read →

IF 98 The Lancet

Sexual and reproductive health rights in the era of artificial intelligence

Bolarinwa O, Adebisi YA, et al. · 2024

Read →

IF 65 The Lancet Psychiatry

The hidden mental health crisis of antimicrobial resistance

Adebisi YA, Olawade DB, Fajembola A · 2023

Read →

IF 14 BMJ Global Health

The Pandemic Treaty, the Pandemic Fund, and the Global Commons

Evaborhene NA, ..., Adebisi YA, et al. · 2023

Read →

IF 14 BMJ Global Health

Caught between violence: Mpox and the perils of neglect in Africa

Evaborhene NA, ..., Adebisi YA, et al. · 2024

Read →

IF 7 BMC Medicine

Economic burden attributable to high BMI-caused cancers: a global analysis

Zheng J, ..., Adebisi YA, et al. · 2025

Read →

IF 6 Social Science & Medicine

The role of AI in enhancing healthcare for people with disabilities

Olawade DB, ..., Adebisi YA, et al. · 2024

Read →

Selected Original Research & Reviews

American Journal of Preventive Medicine

Self-Rated Health by Time Since Smoking Cessation

Adebisi YA, Alshahrani NZ, Ogunkola IO, Jimoh ND · 2025

Read →

European Journal of Public Health

Tobacco smoking by disability status before and after COVID-19 onset: analysis of 1,087,678 adults

Adebisi YA, et al. · 2025

Read →

Tropical Medicine & International Health

Equity-focused analysis of AMR National Action Plans in 14 West African countries

Adebisi YA, Ogunkola IO, et al. · 2025

Read →

Addictive Behaviors

Functional disability and the risk of subsequent smoking initiation: a prospective cohort analysis

Adebisi YA, Alshahrani NZ · 2026

Read →

World Journal of Emergency Surgery

Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action

Adebisi YA & WARNING Collaborators · 2023

Read →

Scientific Reports (Nature)

Improved aerobic capacity in a randomised controlled trial of noncombustible nicotine products

Spicuzza L, ..., Adebisi YA, et al. · 2025

Read →

Journal of Human Hypertension (Nature)

Physical disability and risk of incident hypertension: a prospective cohort analysis

Adebisi YA, et al. · 2025

Read →

Journal of Epidemiology & Population Health

Tobacco smoking and the risk of Long COVID: a prospective cohort study with mediation analysis

Adebisi YA, et al. · 2025

Read →

Selected Academic Opinion & Commentary

Journal of Infectious Diseases

Broadening the Global Mpox Response: A Critical Reflection on Vulnerable Populations

Adebisi YA · 2024

Read →

Journal of Infectious Diseases

Sex Workers and the Mpox Response in Africa

Adebisi YA, et al. · 2024

Read →

Globalization and Health

Balancing the risks and benefits of antibiotic use in a globalised world: the ethics of AMR

Adebisi YA · 2023

Read →

Tropical Medicine & Health

The global AMR response effort must not exclude marginalised populations

Adebisi YA, Ogunkola IO · 2023

Read →

Avicenna Journal of Medicine

Decolonising Epidemiological Research: A Critical Perspective

Adebisi YA · 2023

Read →

American Journal of Tropical Medicine & Hygiene

COVID-19 Highlights the Need for Inclusive Responses to Public Health Emergencies in Africa

Adebisi YA, et al. · 2020

Read →

Selected Book Chapters

Springer Nature Singapore

Rethinking Global Health Research: Decolonization and Equity in Epidemiology

Adebisi YA, Jimoh ND, Bamisaiye A, Ogunkola IO · 2025 · In: Handbook of Concepts in Health, Health Behavior and Environmental Health · ISBN: 978-981-97-0821-5

Read →

Springer Nature Singapore

Utilizing Administrative Data to Inform Health Promotion, Policy, and Practice

Adebisi YA · 2025 · In: Handbook of Concepts in Health, Health Behavior and Environmental Health · ISBN: 978-981-97-0821-5

Read →

Advanced · Global Infection Prevention and Management in Healthcare

Health Inequalities and Antimicrobial Resistance in Africa

Adebisi YA, Farayola RO, Adebusuyi O, Progress A · 2024 · Chapter 22 · ISBN: 978-88-943799-3-8

Read →

World Federation of Public Health Association

The Use of Social Media in Curbing Antimicrobial Resistance in Nigeria

Adebisi YA, Bamisaiye A, Olaoye QD, Awolola TO, Alaran AJ, Lucero-Prisno DE III · 2021 · In: Casebook on Public Health Advocacy · ISBN: 978-84-09-27984-5

Read →

Wuhan University Center for Global Health

Antimicrobial Resistance in Africa

Adebisi YA, Lucero-Prisno III DE, Ekpenyong A · 2019 · In: Liang X (ed.) Case Studies in Global Health · ISBN: 978-7-03-059784-7

Wuhan University Center for Global Health

Neglected Tropical Diseases in Sub-Saharan Africa

Adebisi YA, Lucero-Prisno III DE, Blaise N, Xu L · 2019 · In: Liang X (ed.) Case Studies in Global Health · ISBN: 978-7-03-059784-7

Research Funding

Recent Grants & Fellowships

Over $250,000 in research funding secured across international funders.

Research Fellow · 2025–2026

Nicotine-Containing Products & Infectious/Respiratory Diseases

Università degli Studi di Catania, Italy

Principal Investigator · 2024–2025

Inclusion of Vulnerable Populations in AMR Response in ECOWAS

Robert Koch Institute / German Federal Ministry of Health

Principal Investigator · 2021

Advancing Tobacco Harm Reduction Strategies in Africa Through Research and Capacity Building

Knowledge-Action-Change, London

Fellowship Winner · 2022–2024

Kevin Molloy Fellowship — Tobacco Harm Reduction Capacity Building

Knowledge-Action-Change, London

Principal Investigator · 2020

COVID-19 Risk Communication, Surveillance & Lab Capacity

Royal Society of Tropical Medicine and Hygiene & National Institute for Health and Care Research

In the Media

Featured & Press

Recognition

Awards & Honours

2025

World's Top 2% Scientists

Stanford/Elsevier List — among the most influential researchers in public health

2024

World's Top 2% Scientists

Stanford/Elsevier List — consecutive recognition for citation impact

2021

The Diana Award

Recognised for inspiring research capacity building across Africa

2018

World Health Organization's Innovate4AMR Global Finalist

Top 11 globally for antimicrobial stewardship innovation

Expertise

Technical & Professional Skills

R / Stata / SPSS
Epidemiological Study Design
Survival Analysis (Cox, Poisson)
Logistic & Linear Regression
Linked Admin Data Analysis
Scientific Writing & Publishing
Teaching & Public Speaking
Public Health Consultancy
Project Management
Policy Brief Writing
Public Health Advocacy
International Research Networking

Affiliations

Professional Memberships

Royal Society of Tropical Medicine & Hygiene Oxford University Scientific Society Cambridge University Scientific Society Pharmaceutical Society of Nigeria

Featured Video

Watch

Blog

Latest from the Blog

Thoughts on public health, equity, global health policy, and more.

4 April 2026

When Vaping Overtook Smoking in Great Britain: What This Could Mean for Harm Reduction

In 2024, more adults in Great Britain used e-cigarettes than smoked tobacco for the first time. A commentary on what this milestone means for harm reduction and tobacco control.

Read Article →

4 April 2026

Beyond Willpower: What Our Study Reveals About Smoking Cessation Among Adults Living with Disability

Examining smoking cessation among 147,691 adults living with disability in the UK. Quitting smoking is shaped by social and economic conditions, not just individual behaviour.

Read Article →

4 April 2026

Artificial Intelligence for Public Health in Africa: Why the Real Goal Is Public Value, Not More Pilots

Africa does not need more AI pilots. It needs AI that creates real public value — embedded in governance, aligned with national priorities, and designed to support health equity.

Read Article →

14 March 2026

What Medication Burden Can Tell Us About Smoking and Vaping

A new open-access study examining how prescribed medication burden varies by smoking and e-cigarette use status in England, revealing that ex-smokers carry the highest burden.

Read Article →

17 February 2026

Who Really Benefits from Vaping? New Evidence on Inequality and Tobacco Harm Reduction

An open-access critical review examining socioeconomic disparities in e-cigarette use and whether tobacco harm reduction is reducing or widening smoking-related inequalities.

Read Article →

Contact

Let's collaborate

I welcome enquiries about research collaborations, speaking engagements, peer review, consultancy, or mentorship. Don't hesitate to reach out.